BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 25012820)

  • 1. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
    Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
    Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of DDX39 DEAD box RNA helicase for genome integrity and telomere protection.
    Yoo HH; Chung IK
    Aging Cell; 2011 Aug; 10(4):557-71. PubMed ID: 21388492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock-induced dissociation of TRF2 from telomeres does not initiate a telomere-dependent DNA damage response.
    Petrova NV; Velichko AK; Kantidze OL; Razin SV
    Cell Biol Int; 2014 May; 38(5):675-81. PubMed ID: 24474557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
    Blanco R; Muñoz P; Flores JM; Klatt P; Blasco MA
    Genes Dev; 2007 Jan; 21(2):206-20. PubMed ID: 17234886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage.
    Buscemi G; Zannini L; Fontanella E; Lecis D; Lisanti S; Delia D
    Curr Biol; 2009 May; 19(10):874-9. PubMed ID: 19375317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
    Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
    Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-telomeres in transformed human fibroblasts.
    Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300-mediated acetylation of TRF2 is required for maintaining functional telomeres.
    Her YR; Chung IK
    Nucleic Acids Res; 2013 Feb; 41(4):2267-83. PubMed ID: 23307557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo stoichiometry of shelterin components.
    Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
    J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
    Arkus N
    J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
    Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
    J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2.
    Opresko PL; Fan J; Danzy S; Wilson DM; Bohr VA
    Nucleic Acids Res; 2005; 33(4):1230-9. PubMed ID: 15731343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No DDRama at chromosome ends: TRF2 takes centre stage.
    Feuerhahn S; Chen LY; Luke B; Porro A
    Trends Biochem Sci; 2015 May; 40(5):275-85. PubMed ID: 25845889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the TRF2 telomeric protein in cancer and ageing.
    Muñoz P; Blanco R; Blasco MA
    Cell Cycle; 2006 Apr; 5(7):718-21. PubMed ID: 16582635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
    Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
    Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase.
    Lee GE; Yu EY; Cho CH; Lee J; Muller MT; Chung IK
    J Biol Chem; 2004 Aug; 279(33):34750-5. PubMed ID: 15190070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIN2 mediates functions of TRF2 at human telomeres.
    Kim SH; Beausejour C; Davalos AR; Kaminker P; Heo SJ; Campisi J
    J Biol Chem; 2004 Oct; 279(42):43799-804. PubMed ID: 15292264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.